Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare price negotiations for 2027, the U.S. government said on Friday. Other ...
It's a growing trend among those who have lost weight recently as injectables like Ozempic, Wegovy and Mounjaro have taken off. Courtesy Kya Odom; Brent Allen (right) Kya Odom was forced to face a ...